Drug
Fexuprazan clinical trials
Also written DWP14012.
Includes 1 study of Fexuprazan hydrochloride.
- studies test it
- 32
- open now
- 6
- in phase 3
- 11
- first study started
- 2016
Keep track of what changes. Save the fexuprazan studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Development codes
- DWP14012
- 11
Studies by the year they started
32 studies that test it; most in 2019 (4)
| Year | Studies |
|---|---|
| 2016 | 1 |
| 2017 | 1 |
| 2018 | 3 |
| 2019 | 4 |
| 2020 | 4 |
| 2021 | 4 |
| 2022 | 4 |
| 2023 | 3 |
| 2024 | 4 |
| 2026 | 4 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 14
- Phase 2
- 1
- Phase 3
- 11
- Phase 4
- 2
- No phase
- 4
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 27 · Other 5
Daewoong Pharmaceutical Co. LTD. (27) · Indonesia University (1) · Yonsei University (1) · Ewha Womans University Mokdong Hospital (1) · SUK MIN SEO (1) · Konkuk University Medical Center (1)
Often tested with
Tested in the same studies.
Studies
Open first, then newest update. How each study uses fexuprazan is read from its arms, and is right about nine times in ten.
Testing it · 32
- Fexuprazan for Prevention of Upper Gastrointestinal Bleeding in High Bleeding Risk Patients Receiving Dual Antiplatelet TherapyRecruitingNot applicableSUK MIN SEONCT07479056Written as Fexuprazan 40mg
- Efficacy and Safety of DWP14012 for Long-Term Maintenance Therapy in Patients With Healed Erosive EsophagitisNot yet recruitingPhase 3Daewoong Pharmaceutical Co. LTD.NCT07746518Written as DWP14012 20mg
- Phase 3 to Evaluate the Efficacy and Safety of DWP14012 in Patients With Gastric UlcerNot yet recruitingPhase 3Daewoong Pharmaceutical Co. LTD.NCT07730138Written as DWP14012 40mg (Fexuprazan)
- Study to Evaluate the Efficacy and Safety of Fexuprazan in Prevention of NSAIDs Induced Peptic UlcerNot yet recruitingPhase 4Daewoong Pharmaceutical Co. LTD.NCT07533266Written as Fexuprazan 20mg
- FENOX Trial (Comparative Effectiveness of Fexuprazan Co-therapy in Patients Receiving Non-Vitamin K Antagonist Oral Anticoagulants)Not yet recruitingNot applicableEwha Womans University Mokdong HospitalNCT07497893Written as Fexuprazan
- Study to Evaluate the Efficacy and Safety of DWP14012 in Patients With Non-Erosive Gastroesophageal Reflux Disease (NERD)RecruitingPhase 3Daewoong Pharmaceutical Co. LTD.NCT06121830Written as DWP14012 20mg
- Study Comparing Fexuprazan and Esomeprazole in Patients With Gastroesophageal Reflux DiseaseCompletedPhase 3Indonesia UniversityNCT07326904Written as Fexuprazan
- Efficacy of Fexuprazan for Prevention or Control of Gastritis Symptoms in Patients on Treatment With Systemic SteroidsCompletedPhase 4Yonsei UniversityNCT05946135Written as Fexuprazan Hydrochloride
- Study to Evaluate the Efficacy and Safety of DWP14012-based Triple Therapy in Eradication of Helicobacter PyloriCompletedPhase 3Daewoong Pharmaceutical Co. LTD.NCT06751121Written as DWP14012 40mg
- Study to Evaluate the Safety/Tolerability, PK and PD After Intravenous DWJ1521 Administration in Healthy VolunteersCompletedPhase 1Daewoong Pharmaceutical Co. LTD.NCT06508645Written as DWP14012 injection
- Study to Evaluate the Efficacy and Safety of DWP14012 in Prevention of NSAIDs Induced Peptic UlcerCompletedPhase 3Daewoong Pharmaceutical Co. LTD.NCT04784910Written as DWP14012 20mg
- to Evaluate the Safety/Tolerability and Pharmacokinetics, and Pharmacodynamics of DWP14012 InjectionStatus unknownPhase 1Daewoong Pharmaceutical Co. LTD.NCT06437951Written as Fexuprazan Injection
- A Clinical Study to Investigate the Mass Balance and Biotransformation of [14C]DWP14012 in Healthy Chinese Male SubjectsActive, not recruitingPhase 1Daewoong Pharmaceutical Co. LTD.NCT05868967Written as [14C]DWP14012
- The Efficacy and Safety of DWP14012 in Chinese Patients With Reflux EsophagitisCompletedPhase 3Daewoong Pharmaceutical Co. LTD.NCT05813561Written as DWP14012
- Phase 1 Clinical Trial to Evaluate the Effect of DWP14012 on the Pharmacokinetics of DWC202201 in Healthy SubjectsStatus unknownPhase 1Daewoong Pharmaceutical Co. LTD.NCT05812404Written as DWP14012
- Drug-drug Interactions Between DWP14012 and Aspirin in Healthy SubjectsCompletedPhase 1Daewoong Pharmaceutical Co. LTD.NCT05304845Written as DWP14012
- Drug-drug Interactions Between DWP14012 and DWC202202 in Healthy SubjectsCompletedPhase 1Daewoong Pharmaceutical Co. LTD.NCT05574374Written as DWP14012
- Study to Evaluate the Efficacy and Safety of DWP14012 in Patients With Acute or Chronic GastritisCompletedPhase 3Daewoong Pharmaceutical Co. LTD.NCT04341454Written as DWP14012 X mg
- Study to Evaluate the Safety/Tolerability, Pharmacokinetics, and Pharmacodynamics After Intravenous DWJ1521 Administration in Healthy Adult VolunteersStatus unknownPhase 1Daewoong Pharmaceutical Co. LTD.NCT04827472Written as DWP14012 Tablet
- Treatment Effect According to Timing of Administration of DWP14012 40 mgStatus unknownNot applicableKonkuk University Medical CenterNCT04888819Written as DWP14012
See all 32 studies that test fexuprazan →
Given in every arm · 1 — fexuprazan is usual care beside what is tested
As the comparator · 1 — what is tested is compared with fexuprazan
Codes
What other systems call fexuprazan · ClinicalTrials.gg INT001156
- MeSH (NLM) C000634065fexuprazanConfirmed ClinicalTrials.gov, NLM
- UNII (FDA) BE52S2C1QTFEXUPRAZANConfirmed FDA, NLM, Wikidata
- Wikidata Q123583148fexuprazanConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C171876FexuprazanOne source FDA
- DrugBank DB16078One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C000634065 | fexuprazan | Confirmed ClinicalTrials.gov, NLM |
| UNII (FDA) | BE52S2C1QT | FEXUPRAZAN | Confirmed FDA, NLM, Wikidata |
| Wikidata | Q123583148 | fexuprazan | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C171876 | Fexuprazan | One source FDA |
| DrugBank | DB16078 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.